Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -13.68%713.05M | -14.11%494.14M | -0.41%274.13M | 9.01%1.14B | 8.21%826.07M | 18.78%575.31M | 25.74%275.25M | 16.82%1.04B | 13.61%763.41M | 9.60%484.36M |
| Operating revenue | -13.68%713.05M | -14.11%494.14M | -0.41%274.13M | 9.01%1.14B | 8.21%826.07M | 18.78%575.31M | 25.74%275.25M | 16.82%1.04B | 13.61%763.41M | 9.60%484.36M |
| Other operating revenue | ---- | -17.55%12.03M | ---- | -0.09%28.29M | ---- | 11.01%14.59M | ---- | 29.29%28.31M | ---- | --13.14M |
| Total operating cost | -9.44%637.95M | -10.38%435.61M | -1.70%234.29M | 9.67%960.96M | 704.42M | 21.90%486.07M | 238.35M | 18.71%876.26M | 398.75M | |
| Operating cost | -12.85%467.58M | -14.78%322.17M | -2.86%181.66M | 8.22%732.88M | --536.52M | 25.69%378.05M | --187.02M | 16.80%677.24M | ---- | --300.78M |
| Operating tax surcharges | -15.15%6.19M | -8.31%3.76M | 16.30%1.82M | 50.99%10.37M | --7.3M | 38.77%4.1M | --1.57M | 6.55%6.87M | ---- | --2.96M |
| Operating expense | 3.91%41.79M | 2.66%25.94M | -1.52%11.84M | 2.74%55.93M | --40.22M | -19.97%25.26M | --12.02M | 32.10%54.44M | ---- | --31.57M |
| Administration expense | 7.99%84.53M | 14.08%57.84M | 4.97%26.23M | 23.22%105.13M | --78.27M | 27.06%50.7M | --24.99M | 37.31%85.32M | ---- | --39.91M |
| Financial expense | -42.33%1.49M | -38.43%1.11M | 9.13%1.9M | 315.19%4.52M | --2.58M | 1,184.20%1.8M | --1.74M | -67.69%1.09M | ---- | ---165.77K |
| -Interest expense (Financial expense) | 9.82%4.69M | 39.59%3.81M | 32.94%1.58M | 151.51%6.16M | --4.27M | 94.49%2.73M | --1.19M | -53.31%2.45M | ---- | --1.4M |
| -Interest Income (Financial expense) | 1.78%-2.1M | -11.91%-1.88M | 66.58%-339.13K | -56.46%-2.35M | ---2.14M | -97.01%-1.68M | ---1.01M | -51.30%-1.5M | ---- | ---853.28K |
| Research and development | -7.98%36.37M | -5.18%24.8M | -1.60%10.84M | 1.61%52.13M | --39.53M | 10.35%26.15M | --11.02M | 13.59%51.31M | ---- | --23.7M |
| Credit Impairment Loss | 62.19%-1.6M | 6.97%-2.12M | -862.01%-1.33M | -97.58%-5.18M | ---4.22M | -8.18%-2.28M | --174.62K | -40.67%-2.62M | ---- | ---2.11M |
| Asset Impairment Loss | -760.33%-672.95K | -317.75%-424.09K | -96.26%-478.41K | 52.59%-426.24K | ---78.22K | 119.68%194.76K | ---243.76K | 39.32%-899.13K | ---- | ---989.42K |
| Other net revenue | -47.80%3.5M | -85.08%1.34M | 25.06%1.35M | 20.26%6.61M | 6.71M | 870.94%9M | 1.08M | 1,188.77%5.5M | 0 | 926.59K |
| Fair value change income | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---266.52K | ---- | ---262.13K |
| Invest income | 20,723.02%745.39K | --0 | ---- | -103.80%-3.61K | ---3.61K | ---3.61K | ---3.61K | 475,840,750.00%95.17K | ---- | ---- |
| Net open hedge income | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Including: Investment income associates | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Exchange income | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Asset deal income | -98.96%81.81K | -99.88%10.04K | -127.42%-3.22K | 3,873.38%8.27M | --7.9M | 6,817.96%8.16M | ---1.42K | 828.73%208.19K | ---- | --117.94K |
| Other revenue | 58.65%4.94M | 32.52%3.88M | 174.02%3.16M | -56.07%3.94M | --3.12M | -29.79%2.93M | --1.15M | 218.70%8.98M | ---- | --4.17M |
| Operating profit | -38.77%78.6M | -39.06%59.86M | 8.47%41.19M | 6.00%182.13M | 2.89%128.36M | 13.51%98.24M | -6.19%37.98M | 11.73%171.81M | 7.19%124.75M | 2.78%86.55M |
| Add:Non operating Income | -97.28%12.46K | -97.27%10.86K | -97.94%8.16K | -26.17%816.17K | --457.42K | -61.55%397.2K | --396.7K | 401.79%1.11M | ---- | --1.03M |
| Less:Non operating expense | 90.96%928.07K | 9.91%374.01K | 330.54%174.36K | -53.08%938.02K | --486K | -64.09%340.3K | --40.5K | 50.67%2M | ---- | --947.59K |
| Total profit | -39.47%77.68M | -39.47%59.5M | 7.03%41.03M | 6.49%182M | 3.38%128.33M | 13.47%98.3M | -4.43%38.33M | 11.95%170.92M | 7.32%124.14M | 3.47%86.63M |
| Less:Income tax cost | -35.55%12.23M | -32.28%9.95M | 12.00%7.53M | 7.59%27.13M | --18.98M | 17.00%14.69M | --6.72M | 79.00%25.22M | ---- | --12.55M |
| Net profit | -40.15%65.45M | -40.73%49.56M | 5.97%33.5M | 6.30%154.87M | 3.40%109.35M | 12.87%83.61M | -4.65%31.61M | 5.14%145.7M | 6.99%105.76M | 4.05%74.08M |
| Net profit from continuing operation | -40.15%65.45M | -40.73%49.56M | 5.97%33.5M | 6.30%154.87M | --109.35M | 12.87%83.61M | --31.61M | 5.14%145.7M | ---- | --74.08M |
| Net profit of parent company owners | -40.15%65.45M | -40.73%49.56M | 5.97%33.5M | 6.30%154.87M | 3.40%109.35M | 12.87%83.61M | -4.65%31.61M | 5.14%145.7M | 6.99%105.76M | 4.05%74.08M |
| Earning per share | ||||||||||
| Basic earning per share | -49.50%1.2272 | -46.66%0.9911 | 5.98%0.7444 | 6.17%3.44 | --2.4301 | 12.88%1.858 | --0.7024 | 5.19%3.24 | ---- | --1.646 |
| Diluted earning per share | -49.50%1.2272 | -46.66%0.9911 | 5.98%0.7444 | 6.17%3.44 | --2.4301 | 12.88%1.858 | --0.7024 | 5.19%3.24 | ---- | --1.646 |
| Other composite income | 0 | 0 | ||||||||
| Other composite income of parent company owners | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other composite income of minority owners | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Total composite income | -40.15%65.45M | -40.73%49.56M | 5.97%33.5M | 6.30%154.87M | 109.35M | 12.87%83.61M | 31.61M | 5.14%145.7M | 74.08M | |
| Total composite income of parent company owners | -40.15%65.45M | -40.73%49.56M | 5.97%33.5M | 6.30%154.87M | --109.35M | 12.87%83.61M | --31.61M | 5.14%145.7M | ---- | --74.08M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Zhonglian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Zhonglian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.